3BT9

crystal structure of QacR(E57Q) bound to Dequalinium


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.75 Å
  • R-Value Free: 0.288 
  • R-Value Work: 0.238 
  • R-Value Observed: 0.240 

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history


Literature

QacR-cation recognition is mediated by a redundancy of residues capable of charge neutralization

Peters, K.M.Schuman, J.T.Skurray, R.A.Brown, M.H.Brennan, R.G.Schumacher, M.A.

(2008) Biochemistry 47: 8122-8129

  • DOI: 10.1021/bi8008246
  • Primary Citation of Related Structures:  
    3BT9, 3BTC, 3BTI, 3BTJ, 3BTL

  • PubMed Abstract: 
  • The Staphylococcus aureus multidrug binding protein QacR binds to a broad spectrum of structurally dissimilar cationic, lipophilic drugs. Our previous structural analyses suggested that five QacR glutamic acid residues are critical for charge neutralization and specification of certain drugs ...

    The Staphylococcus aureus multidrug binding protein QacR binds to a broad spectrum of structurally dissimilar cationic, lipophilic drugs. Our previous structural analyses suggested that five QacR glutamic acid residues are critical for charge neutralization and specification of certain drugs. For example, E57 and E58 interact with berberine and with one of the positively charged moieties of the bivalent drug dequalinium. Here we report the structural and biochemical effects of substituting E57 and E58 with alanine and glutamine. Unexpectedly, individual substitutions of these residues did not significantly affect QacR drug binding affinity. Structures of QacR(E57Q) and QacR(E58Q) bound to dequalinium indicated that E57 and E58 are redundant for charge neutralization. The most significant finding was that berberine was reoriented in the QacR multidrug binding pocket so that its positive charge was neutralized by side chain oxygen atoms and aromatic residues. Together, these data emphasize the remarkable versatility of the QacR multidrug binding pocket, illustrating that the capacity of QacR to bind myriad cationic drugs is largely governed by the presence in the pocket of a redundancy of polar, charged, and aromatic residues that are capable of electrostatic neutralization.


    Organizational Affiliation

    School of Biological Sciences, A12, University of Sydney, Sydney, NSW, Australia.



Macromolecules
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
HTH-type transcriptional regulator qacRC [auth A], A [auth B], B [auth D], D [auth E]188Staphylococcus aureus subsp. aureus Mu50Mutation(s): 3 
Gene Names: qacRSAVP031
UniProt
Find proteins for P0A0N3 (Staphylococcus aureus (strain Mu50 / ATCC 700699))
Explore P0A0N3 
Go to UniProtKB:  P0A0N3
Protein Feature View
Expand
  • Reference Sequence
Small Molecules
Ligands 2 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
DEQ (Subject of Investigation/LOI)
Query on DEQ

Download Ideal Coordinates CCD File 
T [auth A]DEQUALINIUM
C30 H40 N4
PCSWXVJAIHCTMO-UHFFFAOYSA-P
 Ligand Interaction
SO4
Query on SO4

Download Ideal Coordinates CCD File 
E [auth B] , F [auth D] , G [auth D] , H [auth D] , I [auth D] , J [auth D] , K [auth A] , L [auth A] , 
E [auth B], F [auth D], G [auth D], H [auth D], I [auth D], J [auth D], K [auth A], L [auth A], M [auth A], N [auth A], O [auth A], P [auth A], Q [auth A], R [auth A], S [auth A], U [auth E], V [auth E], W [auth E], X [auth E], Y [auth E]
SULFATE ION
O4 S
QAOWNCQODCNURD-UHFFFAOYSA-L
 Ligand Interaction
Binding Affinity Annotations 
IDSourceBinding Affinity
DEQ PDBBind:  3BT9 Kd: 1950 (nM) from 1 assay(s)
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.75 Å
  • R-Value Free: 0.288 
  • R-Value Work: 0.238 
  • R-Value Observed: 0.240 
  • Space Group: P 42 21 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 171.24α = 90
b = 171.24β = 90
c = 94.2γ = 90
Software Package:
Software NamePurpose
CNSrefinement
CrystalCleardata collection
CrystalCleardata reduction
d*TREKdata scaling
CNSphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment  



Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2008-08-12
    Type: Initial release
  • Version 1.1: 2011-07-13
    Changes: Version format compliance
  • Version 1.2: 2021-10-20
    Changes: Database references, Derived calculations, Source and taxonomy